Author:
Li Shaling,Huang Yan,Huang Yun,Fu Yongming,Tang Daolin,Kang Rui,Zhou Rongrong,Fan Xue-gong
Funder
National Natural Science Foundation of China
Special National International Technology Cooperation of China
National Major Sciences research Program of China
Natural Science Foundation of Hunan Province
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Testino G, Leone S, Patussi V, Scafato E, Borro P. Hepatocellular carcinoma: diagnosis and proposal of treatment. Minerva Med. 2016;107(6):413–26.
2. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.
3. Balogh J, Victor 3rd D, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour Jr HP. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016;3:41–53.
4. Chacko S, Samanta S. Hepatocellular carcinoma: A life-threatening disease. Biomed Pharmacother. 2016;84:1679–88.
5. Jung CJ, Iyengar S, Blahnik KR, Ajuha TP, Jiang JX, Farnham PJ, Zern M. Epigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation. PLoS One. 2011;6(11):e27740.
Cited by
124 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献